Russia registers the Convasel vaccine against Covid-19 | News
Russia has registered a new vaccine against Covid-19 called Convasel, which was developed by the Saint Petersburg Research Institute of Vaccines and Serums, according to the Federal Medical and Biological Agency of that country.
President Russian reiterates that the objective of the operation in Donbas is to free the population from suffering and genocide
The St. Petersburg Research Institute of Vaccines and Serums, belonging to the Federal Agency, developed this drug, which consists of a solution for intramuscular administration with a dose of 0.5 milliliters.
Said vaccine can be injected to people between 18 and 60 years old, according to the statement of the specialists who also specified that the medicine has an expiration date of six months.
Another of the requirements highlights that the antiocovid vaccine must be stored under temperatures of 2 to 8 degrees Celsius in places protected from light, according to local media.
Although according to the Russian entity the immunogenicity of Convasel, among the adverse effects can be perceived muscle pain, chills, indisposition, fatigue, itching at the site of the puncture and vomiting, among other discomforts noted before the end of the trials in June 2021 .
On the other hand, Russia reported this Friday an increase in positive people for Covid-19 in the latest update of the epidemiological situation with 34,442 cases on the day reaching 17,518,699 positives.